Skip to main content
SpringerLink
Log in

Pathophysiology and Classification of Chemotherapy-Induced Nausea and Vomiting

  • Chapter
  • First Online:
Prevention of Nausea and Vomiting in Cancer Patients

Abstract

The pathophysiology of CINV is not entirely understood; however, it is thought to have many contributing pathways.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 49.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hesketh PJ. Chemotherapy-induced nausea and vomiting. N Engl J Med. 2008;358:2482-2494.

    Google Scholar 

  2. Wang SC, Borison HL. The vomiting center; a critical experimental analysis. Arch Neurol Psychiatry. 1950;63:928-941.

    Google Scholar 

  3. Andrews PL, Horn CC. Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases. Auton Neurosci. 2006;125:100-115.

    Google Scholar 

  4. Miller FR. On gastric sensation. J Physiol. 1910;41:409-415.

    Google Scholar 

  5. Hornby PJ. Central neurocircuitry associated with emesis. Am J Med. 2001;111(suppl 8A):106S-112S.

    Google Scholar 

  6. Gralla RJ. Current issues in the management of nausea and vomiting. Ann Oncol. 1993;4(suppl 3):3-7.

    Google Scholar 

  7. Rapport MM, Green AA, Page IH. Crystalline serotonin. Science. 1948;108:329-330.

    Google Scholar 

  8. Miller AD, Nonaka S, Jakus J. Brain areas essential or non-essential for emesis. Brain Res. 1994;647:255-264.

    Google Scholar 

  9. Moulignier A. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications]. Rev Neurol (Paris). 1994;150:3-15.

    Google Scholar 

  10. Peroutka SJ, Snyder SH. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain. Brain Res. 1981;208:339-347.

    Google Scholar 

  11. Gralla RJ, Itri LM, Pisko SE, et al. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med. 1981;305:905-909.

    Google Scholar 

  12. Leibundgut U, Lancranjan I. First results with ICS 205-930 (5-HT 3 receptor antagonist) in prevention of chemotherapy-induced emesis. Lancet. 1987;1:1198.

    Google Scholar 

  13. Hokfelt T, Pernow B, Wahren J. Substance P: a pioneer amongst neuropeptides. J Intern Med. 2001;249:27-40.

    Google Scholar 

  14. Kris MG, Radford JE, Pizzo BA, et al. Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin. J Natl Cancer Inst. 1997;89:817-818.

    Google Scholar 

  15. Carpenter DO, Briggs DB, Strominger N. Responses of neurons of canine area postrema to neurotransmitters and peptides. Cell Mol Neurobiol. 1983;3:113-126.

    Google Scholar 

  16. Herrstedt J, Dombernowsky P. Anti-emetic therapy in cancer chemotherapy: current status. Basic Clin Pharmacol Toxicol. 2007;101:143-150.

    Google Scholar 

  17. Tonini M, Cipollina L, Poluzzi E, et al. Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther. 2004;19:379-390.

    Google Scholar 

  18. Jordan K, Schmoll HJ, Aapro MS. Comparative activity of antiemetic drugs. Crit Rev Oncol Hematol. 2007;61:162-175.

    Google Scholar 

  19. Roila F, Donati D, Tamberi S, Margutti G. Delayed emesis: incidence, pattern, prognostic factors and optimal treatment. Support Care Cancer. 2002;10:88-95.

    Google Scholar 

  20. Aapro MS, Molassiotis A, Olver I. Anticipatory nausea and vomiting. Support Care Cancer. 2005;13:117-121.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Multidisciplinary Oncology Institute Clinique de Genolier, Genolier, Vaud, Switzerland

    Matti Aapro

  2. Department of Oncology/Haematology, Martin Luther University Hospital Clinic for Internal Medicine, Halle, Germany

    Karin Jordan

  3. Radioonkologie und Nuklearmedizin, Vivantes Klinikum Neukölln Klinik für Strahlentherapie, Berlin, Germany

    Petra Feyer

Authors
  1. Matti Aapro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karin Jordan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Petra Feyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Petra Feyer .

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Healthcare

About this chapter

Cite this chapter

Aapro, M., Jordan, K., Feyer, P. (2013). Pathophysiology and Classification of Chemotherapy-Induced Nausea and Vomiting. In: Prevention of Nausea and Vomiting in Cancer Patients. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-907673-58-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-907673-58-0_2

  • Published:

  • Publisher Name: Springer Healthcare, Tarporley

  • Print ISBN: 978-1-908517-87-6

  • Online ISBN: 978-1-907673-58-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation